Robles, C <br/><br/>
Low-dose cytarabine maintenance therapy vs observation after remission induction in advanced acute myeloid leukemia: an Eastern Cooperative Oncology Group Trial (E5483).  [electronic resource] 

 -  Leukemia  Aug 2000 
 - 1349-53 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0887-6924 
<br/><br/><label>Standard No.: </label>10.1038/sj.leu.2401850  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acute Disease<br/>Adult<br/>Aged<br/>Antimetabolites, Antineoplastic--administration & dosage<br/>Cytarabine--administration & dosage<br/>Dose-Response Relationship, Drug<br/>Female<br/>Humans<br/>Leukemia, Myeloid--drug therapy<br/>Male<br/>Middle Aged<br/>Prospective Studies<br/>Recurrence<br/>Remission Induction